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Introduction
The major human Fe transport protein is the glycoprotein transferrin (Tf)' (1) . Tf is necessary for normal and malignant cell growth in serum-free culture (2) , and cells display specific Tf receptors (TfR) (3) (4) (5) (6) (7) (8) . Recently, monoclonal antibodies were used to detect TfR display by cultured cells (9, 10) and in human tissues (11) . One such antibody, 42/6 (12) , blocks Tf binding to specific receptors and inhibits growth of human hemopoietic cells in culture (12, 13) . A similar antibody to murine TfR has been described (14) . These reagents provide innovative tools for investigating roles of Tf and Fe in hemopoietic cell growth.
We have previously studied effects of 42/6 and other antiTfR on growth of normal and malignant myeloid cells (13) . 42/6 was a potent inhibitor of acute nonlymphocytic leukemia (ANLL) cell line and granulocyte/macrophage progenitor growth. However, 42/6 did not inhibit growth of some ANLL blast colonies, and free Fe was able to reverse growth inhibition of some ANLL cell lines but not others. Further, these studies were conducted using conventional fetal calf serum (FCS) cultures and others have questioned the efficiency of bovine Tf-human TfR interactions (15, 16) .
In the present studies, we used serum-free cultures of specially adapted ANLL cell lines to further investigate roles of Tf, Fe, and TfR in ANLL cell growth, and mechanisms of 42/6 growth inhibition.
adapted to serum-free culture by stepwise reduction in FCS concentration. These cells were further adapted to culture without Tf by serial Tf reduction and culture with 5 MM ferric nitriloacetate (FeNTA) (EISFe medium-ethanolamine, insulin, and selenium with FeNTA). KG-1 cells were adapted to serum-free and Tf-free culture in a similar manner. Cells were passed at intervals of 2-3 d for > 6 mo in ETIS. HL60 and KG-l cells were grown in EIS-Fe for >3 mo.
For growth assays, 2 X 105/ml cells were seeded into 25-cm2 tissue cultures flasks (Falcon Plastics, Cockeysville, MD), and viable cell counts were performed using trypan-blue dye exclusion.
Bone marrow and leukemia cell cultures. Bone marrow from four normal donors and peripheral blood from one patient each with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis were obtained in heparin. Cells were characterized and separated on Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ) as previously described (13, 19) . The mononuclear cells were collected by aspiration and washed three times in Iscove's modification of Dulbecco's minimum essential medium (Grand Island Biological Co., Grand Island, NY). The cells were plated at 106/ml in Iscove's modification of Dulbecco's medium with 10% FCS and 10% placentaconditioned medium as previously described (19) . When cultures reached a density of 2 X 106/ml, cells were resuspended at the initial cell concentration with fresh media containing placenta-conditioned medium. Viable cell counts were performed on days 1, 3, 6, 9, and 12, and cells were removed on these days for morphology, surface marker staining, and cell cycle analysis. In some studies, cell numbers limited the studies that could be performed.
Induction of ANLL cell differentiation. HL60 cells were induced for granulocytic differentiation by treatment with various concentrations of dimethyl sulfoxide (DMSO) (17) . Differentiation was assessed by morphology, reactivity with monoclonal antibody to polymorphonuclear leukocyte 29 (kindly provided by Dr. Edward Ball, Dartmouth University, Hanover, NH), and nitroblue tetrazolium dye reduction (20) .
In two studies, HL60 cells were incubated with 1.0% DMSO for 24 or 48 h, washed and plated with DMSO or DMSO + 10 isg/ml of 42/6. Viable cell counts were performed every other day.
Characterization of cells in culture. To characterize cells for morphology, cytospin preparations were stained with Wright-Giemsa stain and 500 cell differential counts were performed. Cells were stained by immunofluorescence with monoclonal anti-TfR and other antibodies as previously described (13, 21) . TfR detected by monoclonal antibodies are referred to below as "immunologically detectable" TfR. 5 Assay for intracellular ferritin. The ferritin content of HL60 cells was assessed by radioimmunoassay. Cell lysates were prepared using a modification of previously described techniques (26) by several cycles of freezing and thawing on acetone/dry ice. Complete lysis of 107 FCS, ETIS, and EIS-Fe cultured HL60 cells in 0.1 M phosphate buffer, pH 7.4, containing 0.1% human albumin and 0.02% azide, was confirmed by visual examination. The final volume was adjusted to 2 ml after ultracentrifugation by using the same buffer. Radioimmunoassay with '251-rabbit, anti-human ferritin was performed according to the manufacturer's recommendations (Becton, Dickinson & Co., Orangeburg, NY).
Results

Role of Fe in anti-TIR inhibition. In previous studies, soluble
Fe reversed 42/6 inhibition of FCS-cultured KG-1 but not HL60 cells (13) . To determine whether results were due to different abilities to grow with soluble Fe, we examined the ability of the cells to grow in EIS media with 5 > 20 MM and reduced growth with concentrations < 2.5 uM. The doubling time of HL60 cells in EIS-Fe was slightly longer than cells in ETIS (Fig. 1) (-40 h) . Cells adapted to EIS-Fe or ETIS or cultured with FCS did not grow when cultured in EIS medium without Fe (Fig. 1) . Thus human myeloid leukemia cells could be adapted to Tf-free medium, but remained dependent on exogenous Fe.
As reported previously (13) (Fig. 3 A) . Tf affinity and receptor number were also similar (Table I) . Tf receptors were present on EIS-Fe cells (Fig. 3 B) and affinity was also similar (Table I) . However, the number of TfR sites was reduced by nearly 1 log (Table I) . Thus, serum-free culture did not alter Tf affinity, but Tf-free culture resulted in decreased TfR number.
To assess whether HL60 cells cultured with FCS, ETIS, or EIS-Fe differed in cytosolic ferritin content, cell lysates were prepared from each cell line. Lysates of FCS and ETIS cells contained 38 and 40 ng/ml ferritin. In contrast, EIS-Fe cell lysates contained 435 ng/ml. Therefore, EIS-Fe cultured HL60 cells displayed fewer TfR and decreased TfR were associated with increased cytosolic ferritin.
Studies with labeled 42/6 also showed specific binding to all 3 HL60 lines (Fig. 4) . For these calculations, the molecular weight of immunoglobulin A (IgA) was assumed to be 180,000. Affinities were slightly less than those for Tf (Table I ). The number of 42/6 binding sites appeared consistently higher than those for Tf (Table I) Relationship between TIR display and 42/6 inhibition. Although FeNTA apparently overcame 42/6 inhibition in some settings, these observations did not explain failure to inhibit some ANLL and granulocyte/macrophage progenitor colony-forming cells (13) . Recent studies suggest varying levels of TfR display by dividing T lymphoblasts (27 In two studies, FCS HL60 cells were grown with 1.25% DMSO, and day 5 cell growth was 76% of that of FCS controls.
DMSO and 42/6, cell growth was 66% of FCS controls (or 87% of DMSO cultures without 42/6). Thus, leukemia cells that were induced to differentiate decreased their TfR display, and were able to undergo several cycles of cell division despite the presence of 42/6.
In ETIS media, the situation was slightly more complex. In the presence of 1.0-1.25% DMSO, cell growth decreased slightly (Fig. 5) . In contrast to results obtained with FCS cultures where growth eventually ceases with DMSO, with more prolonged exposure to DMSO, cell growth slowed even further, but did not cease. These results presumably reflect incomplete and slower cellular differentiation in serum-free cultures, and continued cell growth by cells unaffected by DMSO. When 42/6 was added to control HL60 cultures after 24 or 48 h in culture, cell growth ceased (Fig. 5) , and when cultures were initiated with DMSO and 42/6, growth inhibition was still observed (data not shown). However, when 42/6 was added after 24-72 h of exposure to DMSO, cell growth continued for at least 2 d (Fig. 5) . The later the 42/6 was added, the less inhibition observed. When DMSO-treated cells were washed and placed in Tf-free cultures, cell growth ceased, indicating DMSO-treated cells remained dependent on Tf for growth. Thus, HL60 cells induced to differentiate and to decrease TfR display became refractory to 42/6 inhibition.
Discussion
TfR are displayed by proliferating normal and malignant cells (3-1 1) , and deprivation of Tf causes cell-cycle dependent arrest of lymphocyte proliferation (5, 6). Anti-TfR monoclonal antibodies also inhibit growth of normal and malignant cells ( 12, 13, 30) , but their mechanism of action is unclear. Some antiTfR inhibit Tf binding (12, 13) , but others cause growth inhibition without this finding (13) . Studies using rat, antimouse TfR suggest a poor relationship between inhibition of Fe uptake and growth inhibition (14) . In previous studies that used 42/6, Fe reversed growth inhibition of some cells (13, 30) , but not others ( 12, 13) . Finally, tumor-associated proteins, including melanoma p97 and the B-lym onc gene product (31) , are homologous to Fe-binding proteins. These observations suggest Tf might act as a "growth factor-like" molecule, and anti-TfR by preventing this activity. Therefore, although Tf appears important for normal and malignant cell growth, its h to decrease TfR, and then exposed to 42/6, cells were able to undergo several cycles of cell division and increase in number. In contrast, control cultures not exposed to DMSO failed to grow from the outset when cultured with antibody. Fresh leukemia cells also undergo differentiation in cultures such as the ones used here (19) . For the two patients studied here, initial blast cell percentages were 80 and 75%; at termination of the culture, 37-74% of cells were myelocytes or macrophages. Therefore, HL60 differentiation reduces TfR display and makes cells refractory to 42/6 inhibition. Dividing normal and fresh leukemia cells display varying numbers of TfR, and might also escape 42/6 inhibition by decreasing TfR display through differentiation.
Monoclonal anti-TfR have broadened understanding of Tf and Fe roles in cellular proliferation (10) . Our studies indicate a major Tf function is Fe provision to dividing malignant cells and support the link between decreased TfR and differentiation. Cells escape inhibition by anti-TfR 42/6 either by using nonTf sources of Fe, or decreasing TfR display. The exact mechanism in the latter case is unclear, but further studies will define relationships between Fe loading, decreased TfR display, differentiation, and biochemical mechanisms of Tf independence.
